![](/img/cover-not-exists.png)
2866 Antitumor activity of the Anti-PD-1 antibody pembrolizumab in subgroups of patients with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC): Exploratory analyses from KEYNOTE-012
Chow, L., Mehra, R., Haddad, R., Gupta, S., Weiss, J., Berger, R., Burtness, B., Tahara, M., Keam, B., Le, D., Cheng, J., Heath, K., Pathiraja, K., Seiwert, T.Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)31604-5
Date:
September, 2015
File:
PDF, 60 KB
english, 2015